Insulin Management
Insulin Management
04/20/2021
In an effort to improve adherence and remove the burden of treatment for patients with type 2 diabetes, researchers examined the efficacy and safety of a new once-a-week injectable insulin.
04/20/2021
Lung Cancer Screening
Lung Cancer Screening
03/10/2021
The US Preventive Services Task Force has updated its recommendations on who and when to screen for lung cancer.
03/10/2021
prediabetes
prediabetes
02/09/2021
Prediabetes is often used to identify patients who are at an increased risk of developing diabetes. However, multiple prediabetes definitions and a lack of characterization makes this common association...
02/09/2021
Type 2 Diabetes
Type 2 Diabetes
01/18/2021
While the relationship between selective serotonin reuptake inhibitors use and the risk of type 2 diabetes in adults has been a matter of concern for health care providers, little is known about this...
01/18/2021
FDA
FDA
12/21/2020
This roundup of recent FDA approvals details the authorization of a new COVID-19 vaccine and options for lung and prostate cancer.
12/21/2020
Diabetes mellitus
Diabetes mellitus
10/27/2020
Previous research has suggested an association between green tea and coffee and mortality risk among patients with diabetes. However, the relationship is currently unclear.
10/27/2020
Screening
Screening
10/06/2020
The American Thoracic Society has released a scientific statement addressing disparities in lung cancer screening eligibility and focusing on barriers to screening and strategies to improve screening rates...
10/06/2020
Cardiometabolic risk
Cardiometabolic risk
08/31/2020
Focusing on body mass index over genetics could be vital for identifying individuals with the greatest risk of developing diabetes, according to researchers at ESC Congress 2020.
08/31/2020
prediabetes
prediabetes
07/21/2020
While cinnamon has been shown to have glucose-lowering properties, whether these could be employed in patients with prediabetes to prevent disease progression is unknown.
07/21/2020
Diabetes Q&A
Diabetes Q&A
05/20/2020
In a recent cohort study, researcher examined the risk of serious renal events associated with the use of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors.
05/20/2020